Products
Pivekimab Sunirine Biosimilar Antibody-Drug Conjugate (CD123) for Research
Pre-made Pivekimab Sunirine benchmark antibody (Whole mAb ADC, anti-IL3RA therapeutic antibody, Anti-CD123/IL3R/IL3RX/IL3RY/hIL-3Ra Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Order Information
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-INN-961-1mg | 1mg | |
| GMP-Bios-INN-961-10mg | 10mg | |
| GMP-Bios-INN-961-100mg | 100mg | |
| GMP-Bios-INN-961-xmg | ≥100mg |
Product Details
| Products Name (INN Index) | Pre-Made Pivekimab Sunirine Biosimilar, Whole Mab Adc, Anti-Il3Ra Antibody: Anti-CD123/IL3R/IL3RX/IL3RY/hIL-3Ra therapeutic antibody Drug Conjugate |
| INN Name | Pivekimab Sunirine |
| Target | IL3RA |
| Format | Whole mAb ADC |
| Derivation | Chimeric Humanized |
| Species Reactivity | human |
| CH1 Isotype | IgG1 - kappa |
| VD LC | IgG1 - kappa |
| Highest_Clin_Trial (Jan '20) | |
| Est. Status | |
| 100% SI Structure | |
| 99% SI Structure | |
| 95-98% SI Structure | |
| Year Proposed | |
| Year Recommended | |
| Companies | ImmunoGen Inc. (Cambridge MA USA) |
| Conditions Approved | |
| Conditions Active | |
| Conditions Discontinued | |
| Development Tech | 0 |
About target - IL3RA
1. Protein Interleukin-3 receptor subunit alpha
2. Gene IL3RA
3. Organism Homo sapiens (Human)
Function
This is a receptor for interleukin-3.
Miscellaneous
The gene coding for this protein is located in the pseudoautosomal region 1 (PAR1) of X and Y chromosomes.
